Zymergen (ZY) and The Competition Head-To-Head Comparison

Zymergen (NASDAQ:ZY – Get Rating) is one of 40 public companies in the “Commercial physical research” industry, but how does it weigh in compared to its rivals? We will compare Zymergen to related companies based on the strength of its analyst recommendations, institutional ownership, dividends, risk, profitability, earnings and valuation.

Institutional & Insider Ownership

48.8% of Zymergen shares are owned by institutional investors. Comparatively, 56.5% of shares of all “Commercial physical research” companies are owned by institutional investors. 10.6% of shares of all “Commercial physical research” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Zymergen and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Zymergen	$16.74 million	-$361.79 million	-0.18
Zymergen Competitors	$2.79 billion	$101.13 million	22.16

Zymergen’s rivals have higher revenue and earnings than Zymergen. Zymergen is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Zymergen and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zymergen	3	5	0	0	1.63
Zymergen Competitors	99	741	1293	30	2.58

Zymergen presently has a consensus target price of $6.75, suggesting a potential upside of 283.52%. As a group, “Commercial physical research” companies have a potential upside of 26.48%. Given Zymergen’s higher possible upside, equities analysts clearly believe Zymergen is more favorable than its rivals.

Profitability

This table compares Zymergen and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zymergen	-2,160.81%	-213.99%	-64.50%
Zymergen Competitors	-255.16%	-16.00%	-2.18%

Summary

Zymergen rivals beat Zymergen on 11 of the 12 factors compared.

About Zymergen (Get Rating)

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.